MOLEX INC (MOLX) - Profit Tracks

By
A A A

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why AVY and MOLX have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

Avery Dennison Corporation ( AVY ) announced fourth-quarter profit of 39 cents per share on January 31 that missed analysts? expectations by 15.22%. The Zacks Consensus Estimate for the current year slid to $1.99 per share from $2.69 per share in the last 30 days as next year?s estimate dipped 48 cents per share to $2.50 per share in that time span.

Molex Incorporated ( MOLX ) posted a second-quarter profit of 38 cents per share on January 25, which came in 3 cents wider than the average forecast. The Zacks Consensus Estimate for the full year fell to $1.61 per share from $1.72 per share over the past month. For 2013, analysts expect a profit of $1.83 per share, compared to last month?s projection for a profit of $1.97 per share.

Here is a synopsis of why ABAX and TECH have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Abaxis Inc ( ABAX ) third-quarter profit of 13 cents per share, posted on January 26, lagged analysts? projections by 18.75%. Estimate for current year slid 5 cents per share to 54 cents per share over a month as next year?s estimate dipped 5 cents per share to 82 cents per share in that time span.

Techne Corporation ( TECH ) reported a second-quarter profit of 76 cents per share on January 31 that fell 3.80% short of the Zacks Consensus Estimate. The full-year average forecast is currently $3.31 per share, compared with last month?s projection of $3.39 per share. Next year?s forecast dropped to $3.49 per share from $3.61 per share in the same period.
 
ABAXIS INC ( ABAX ): Free Stock Analysis Report
 
AVERY DENNISON ( AVY ): Free Stock Analysis Report
 

MOLEX INC ( MOLX ): Free Stock Analysis Report
 
TECHNE CORP ( TECH ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: ABAX , AVY , MOLX , TECH

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Visualizing Healthcare MG
Visualizing Healthcare MG           
Power on/Power Off IPC
Power on/Power Off IPC              
Spot the Dropout RRC
Spot the Dropout RRC                
Power on/Power Off
Power on/Power Off                  

Stocks

Referenced

Most Active by Volume

10,342,964
  • $16.21 ▼ 0.92%
9,137,252
  • $112.42 ▼ 0.77%
8,317,043
  • $10.30 ▼ 1.90%
8,244,767
  • $2.638 ▲ 10.38%
8,226,075
  • $10.37 ▲ 0.68%
8,169,396
  • $27.409 ▲ 2.16%
7,289,601
  • $13.595 ▼ 1.06%
7,198,473
  • $104.571 ▼ 0.99%
As of 8/31/2015, 10:18 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com